Elizabeth D. Barnett, MD
Professor
Boston University Chobanian & Avedisian School of Medicine
Pediatrics
Infectious Diseases

MD, Boston University
SB/ScB, Brown University



For more than 25 years at BUSM/BMC, Dr. Barnett has been a clinical and academic leader who has achieved international prominence in Travel and Tropical Medicine with a particular focus on refugee health and the medical needs of new immigrant families. She has served as the PI of the BMC Refugee Health Assessment Program for more than 20 years and also is Site Director for the GeoSentinel Program in partnership with the Centers for Disease Control. In addition, Dr. Barnett has studied the safety and dissemination of childhood immunizations and is a leader in the BMC Center for Immunization Safety and Assessment.

Nationally recognized for her work in Pediatric Infectious Diseases, Dr. Barnett is a member of the Committee on Infectious Diseases of the American Academy of Pediatrics, the body that publishes the Red Book, which is the authoritative text for the treatment of Pediatric Infectious Diseases. She has published more than 90 peer-reviewed manuscripts and presented at numerous national and international meetings and seminars.

Dr. Barnett completed her pediatric residency at Boston City Hospital (BCH) and Children’s Hospital, Boston. After serving as a Chief Resident in the Department of Pediatrics, she completed fellowship training in Pediatric Infectious Diseases at BCH under the direction of Drs. Pelton and Jerome Klein.


A Phase lll Randomized, Double-blind, Placebo-Controlled Three-Lot Consistency Study in Healthy Adult Volunteers to Assess Immunogenicity, and Clinical Acceptability of a Single-dose of the Live Oral
03/06/2014 - 03/05/2017 (PI)
PaxVax, Inc.


A Phase lll Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200
11/01/2013 - 10/31/2016 (PI)
PaxVax, Inc.


A Multicenter, randomized, observer-blinded, active-controlled study evaluating the safety, tolerability pharmacokinetics an efficacy of ceftaroline versus cetriaxone in pediatric subjects with compli
01/01/2013 - 06/30/2015 (PI)
Cerexa, Inc.


A multi-center, randomized, observer-blinded, active-controlled study evaluating the safety, tolerability, pharmacokinetics and efficacy of ceftaroline versus cetriaxone plus vancomycin in pediatric
10/01/2012 - 09/30/2013 (PI)
Cerexa, Inc.


Long Term Immunity and Safety following Vaccination with the Japanese Ecephalitis Vaccine IC51 in a Pediatric Population in Non-endemic Countries
12/12/2011 - 12/11/2012 (PI)
Intercell AG


IMMUNOGENICITY AND SAFETY OF THE JAPANESE ENCEPHALITIS VACCINE IC51 (IXIARO, JESPECT) IN A PEDIATRIC POPULATION IN NON-ENDEMIC COUNTRIES. UNCONTROLLED, OPEN-LABEL PHASE 3 STUDY
02/01/2010 - 06/30/2012 (PI)
Intercell AG


Evaluation of Impact of Antimicrobial Therapy on Carriage of Susceptible and Resistant Streptococcus Pneumoniae
09/01/1999 - 06/30/2004 (PI)
SmithKline Beecham

Use of Intrapulmonary Percussive Ventilation to Prevent Respiratory Disease in Adolescents with Impaired Pulmonary Function
09/01/1999 - 08/31/2000 (PI)
Deborah Munroe Noonan Memorial Fund Medical Fdn Inc


A Phase 3, Randomized, Observer-Blinded Study to Evaluate the Relative Safety, Tolerability, Efficacy, and Immunogenicity of a Modified RNA Vaccine against Influenza Compared to a Licensed Inactivated Influenza Vaccine in Healthy Adults Greater than or Eq
11/11/2022 - 11/11/2025 (PI)
Pfizer, Inc

A MASTER PHASE 1/2/3 PROTOCOL TO INVESTIGATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF BIVALENT BNT162b2 RNA-BASED VACCINE CANDIDATE(S) IN HEALTHY CHILDREN (Pfizer C4591048)
09/23/2022 - 09/23/2025 (PI)
Pfizer, Inc

CISA Clinical Vaccine Safety Evaluation Boston Contributing Tasks 1 and 2
09/29/2022 - 09/28/2024 (PI)
Centers for Disease Control and Prevention/DHHS

A PHASE 3 MASTER PROTOCOL TO EVALUATE ADDITIONAL DOSE(S) OF BNT162b2 IN HEALTHY INDIVIDUALS PREVIOUSLY VACCINATED WITH BNT162b2 (Pfizer C4591031, Protocol Amendment 1, 27 May 2021)
07/06/2021 - 07/06/2024 (PI)
Pfizer, Inc

A PHASE 1, OPEN-LABEL DOSE-FINDING STUDY TO EVALUATE SAFETY, TOLERABILITY, AND IMMUNOGENICITY AND PHASE 2/3 PLACEBO-CONTROLLED, OBSERVER-BLINDED SAFETY, TOLERABILITY, AND IMMUNOGENICITY STUDY OF A SARS-COV-2 RNA VACCINE CANDIDATE AGAINST COVID-19 IN HEALT
03/08/2021 - 03/08/2024 (PI)
Pfizer, Inc

A PHASE 1/2, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND, DOSE-FINDING STUDY TO DESCRIBE THE SAFETY, TOLERABILITY, IMMUNOGENICITY, AND POTENTIAL EFFICACY OF SARS-COV-2-RNA VACCINE CANDIDATES AGAINST COVID-19 IN HEALTHY ADULTS
05/29/2020 - 12/31/2023 (PI)
Pfizer, Inc

A Phase 3, Randomized, Double- or Observer-Blinded, Placebo Controlled Trial to Evaluate the…
03/09/2020 - 12/31/2023 (PI)
Pfizer, Inc

GeoSentinel Freezer Project
11/15/2022 - 11/14/2023 (PI)
International Society of Travel Medicine

A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY OF A 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS
06/29/2020 - 06/29/2023 (PI)
Pfizer, Inc

A Phase 2b Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Respiratory Syncytial Virus (RSV) Vaccine in Pregnant Women 18 Through 49 Years of Age and Their Infants
08/22/2019 - 04/30/2023 (PI)
Pfizer, Inc

Showing 10 of 20 results. Show All Results

Title

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Reifler KA, Wheelock A, Hall SM, Salazar A, Hassan S, Bostrom JA, Barnett ED, Carrion M, Hochberg NS, Hamer DH, Gopal DM, Bourque D. Chagas cardiomyopathy in Boston, Massachusetts: Identifying disease and improving management after community and hospital-based screening. PLoS Negl Trop Dis. 2024 Jan; 18(1):e0011913.View Related Profiles. PMID: 38241361
     
  2. Sabharwal V, Taglauer E, Demos R, Snyder-Cappione J, Shaik-Dasthagirisaheb YB, Parker-Kelleher S, Hunnewell J, Boateng J, Clarke K, Yuen R, Barnett ED, Wachman EM, Yarrington CD. Comparison of Anti-SARS-CoV-2-Specific Antibody Signatures in Maternal and Infant Blood after COVID-19 Infection versus COVID-19 Vaccination during Pregnancy. Am J Perinatol. 2023 Oct 31.View Related Profiles. PMID: 37774748
     
  3. Barnett ED, Wheelock AB, MacLeod WB, McCarthy AE, Walker PF, Coyle CM, Greenaway CA, Castelli F, López-Vélez R, Gobbi FG, Trigo E, Grobusch MP, Gautret P, Hamer DH, Kuhn S, Stauffer WM. Infections with long latency in international refugees, immigrants, and migrants seen at GeoSentinel sites, 2016-2018. Travel Med Infect Dis. 2023; 56:102653.View Related Profiles. PMID: 37852594; PMCID: PMC10760402; DOI: 10.1016/j.tmaid.2023.102653;
     
  4. Schmader KE, Liu CK, Flannery B, Rountree W, Auerbach H, Barnett ED, Schlaudecker EP, Todd CA, Poniewierski M, Staat MA, Harrington T, Li R, Broder KR, Walter EB. Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial. Immun Ageing. 2023 Jul 01; 20(1):30. PMID: 37393237; PMCID: PMC10314373; DOI: 10.1186/s12979-023-00355-7;
     
  5. Huits R, Angelo KM, Amatya B, Barkati S, Barnett ED, Bottieau E, Emetulu H, Epelboin L, Eperon G, Medebb L, Gobbi F, Grobusch MP, Itani O, Jordan S, Kelly P, Leder K, Díaz-Menéndez M, Okumura N, Rizwan A, Rothe C, Saio M, Waggoner J, Yoshimura Y, Libman M, Hamer DH, Schwartz E. Clinical Characteristics and Outcomes Among Travelers With Severe Dengue : A GeoSentinel Analysis. Ann Intern Med. 2023 Jul; 176(7):940-948.View Related Profiles. PMID: 37335991; PMCID: PMC10760980; DOI: 10.7326/M23-0721;
     
  6. Piyaphanee W, Stoney RJ, Asgeirsson H, Appiah GD, Díaz-Menéndez M, Barnett ED, Gautret P, Libman M, Schlagenhauf P, Leder K, Plewes K, Grobusch MP, Huits R, Mavunda K, Hamer DH, Chen LH. Healthcare seeking during travel: an analysis by the GeoSentinel surveillance network of travel medicine providers. J Travel Med. 2023 May 18; 30(3).View Related Profiles. PMID: 36637429
     
  7. Woolf AD, Stierman BD, Barnett ED, Byron LG. Drinking Water From Private Wells and Risks to Children. Pediatrics. 2023 Feb 01; 151(2). PMID: 36995188
     
  8. Woolf AD, Stierman BD, Barnett ED, Byron LG. Drinking Water From Private Wells and Risks to Children. Pediatrics. 2023 Feb 01; 151(2). PMID: 36995187
     
  9. Sabharwal V, Demos R, Snyder-Cappione J, Parker SE, Shaik-Dasthagirisaheb Y, Hunnewell J, Boateng J, Clarke K, Yuen R, Barnett E, Yarrington C, Taglauer E, Wachman EM. Cytokine levels in maternal and infant blood after COVID-19 vaccination during pregnancy in comparison with unvaccinated controls. J Reprod Immunol. 2023 Mar; 156:103821.View Related Profiles. PMID: 36764228; PMCID: PMC9884398; DOI: 10.1016/j.jri.2023.103821;
     
  10. Wachman EM, Snyder-Cappione J, Devera J, Boateng J, Dhole Y, Clarke K, Yuen RR, Parker SE, Hunnewell J, Ferraro R, Jean-Sicard S, Woodard E, Cruikshank A, Sinha B, Bartolome R, Barnett ED, Yarrington C, Taglauer ES, Sabharwal V. Maternal, Infant, and Breast Milk Antibody Response Following COVID-19 Infection in Early Versus Late Gestation. Pediatr Infect Dis J. 2023 Mar 01; 42(3):e70-e76.View Related Profiles. PMID: 36729773; PMCID: PMC9935237; DOI: 10.1097/INF.0000000000003802;
     
Showing 10 of 120 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 120 publications over 33 distinct years, with a maximum of 11 publications in 2013

YearPublications
19911
19923
19931
19943
19952
19961
19972
19982
19992
20004
20011
20022
20034
20043
20054
20073
20083
20092
20106
20112
20127
201311
20144
20153
20164
20178
20186
20194
20202
20216
20225
20238
20241
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Travel and Tropical Medicine
refugee health
immigrant health
Pediatric Infectious Diseases
Contact for Mentoring:

774 Albany St
Boston MA 02118
Google Map


Barnett's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department